- Research works
- 79 ▲ 120% vs 2018-21
- Citations
- 1.1k 13.4 per fractional work
- Top-10% rate
- 13.9% all institutions 10.0%
- Open access
- 52% world 40%
- International
- 18% world 18%
Not ranked overall: Coherus BioSciences (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Coherus BioSciences (United States) work in?
In 2022-now, 55% of research at Coherus BioSciences (United States) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (15%). It does 2.2× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 17 fields, with their numbers
- Health Sciences2455.2%
- Medicine2353.9%
- Nursing00.7%
- Health Professions00.6%
- Life Sciences1637.9%
- Physical Sciences23.5%
- Engineering01.0%
- Materials Science01.0%
- Chemistry00.8%
- Chemical Engineering00.2%
- Computer Science00.2%
- Mathematics00.2%
- Environmental Science00.1%
- Social Sciences23.5%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.7×. Every wedge is a field page.
All 17 fields, with their numbers
- Immunology and Microbiology14.67×6 works
- Biochemistry, Genetics and Molecular Biology4.18×10 works
- Medicine2.80×23 works
- Economics, Econometrics and Finance1.48×1 works
- Nursing1.35×0 works
- Chemical Engineering0.68×0 works
- Chemistry0.49×0 works
- Neuroscience0.33×0 works
- Pharmacology, Toxicology and Pharmaceutics0.33×0 works
- Materials Science0.28×0 works
- Health Professions0.24×0 works
- Mathematics0.13×0 works
- Engineering0.07×0 works
- Agricultural and Biological Sciences0.03×0 works
- Computer Science0.03×0 works
- Environmental Science0.02×0 works
- Social Sciences0.02×0 works
- Immunology and Microbiology 14.7×
- Biochemistry, Genetics and Molecular Biology 4.2×
- Medicine 2.8×
- Economics, Econometrics and Finance 1.5×
- Nursing 1.4×
- Chemical Engineering 0.7×
- Chemistry 0.5×
- Neuroscience 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Materials Science 0.3×
- Health Professions 0.2×
- Mathematics 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.0×
- Computer Science 0.0×
- Environmental Science 0.0×
- Social Sciences 0.0×
Who are the top researchers at Coherus BioSciences (United States)?
Ranked on the quality score, Martin Oft, Daniel J. Chin and Scott McCauley lead among researchers whose main affiliation is Coherus BioSciences (United States).
- 1
Martin Oft
United States · #223,880 worldwide 7.1k citations · 123 works
- 2
Daniel J. Chin
United States · #287,385 worldwide 6k citations · 74 works
- 3
Scott McCauley
United States · #655,739 worldwide 2k citations · 31 works
- 4
Varun N. Kapoor
United States · #690,470 worldwide 937 citations · 34 works
- 5
Barbara K. Finck
United States · #802,907 worldwide 4.8k citations · 18 works
- 6
Navneet P. Ratti
United States · #1,010,856 worldwide 1.3k citations · 34 works
- 7
Peter Van Vlasselaer
United States · #1,062,113 worldwide 2.9k citations · 64 works
- 8
Scott L. Klakamp
United States · #1,126,585 worldwide 1.5k citations · 53 works
Which keywords describe research at Coherus BioSciences (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Tumor Microenvironment, Cancer, Chemotherapy, Monoclonal Antibodies, Immune Checkpoint Blockade, PD-1 and PD-L1, Immunotherapy and Cancer Therapy.
- Molecular Subtypes
- Tumor Regression
- Leukemia
- CAR T Cells
- Tumor Antigen
- Dendritic Cells
- Innate Immunity
- Metabolism
- Targeted Therapy
- Antimicrobial Agents
- Fc Receptors
- Hematological Malignancies
- Bioanalytical Methods
- Therapeutic Antibodies
- Biopharmaceuticals
- Cancer Therapy
- Immunotherapy
- PD-1 and PD-L1
- Monoclonal Antibodies
- Cancer
- Tumor Microenvironment
- Chemotherapy
- Immune Checkpoint Blockade
- Inflammation
- Cancer Immunotherapy
- Immunity
- Immunogenicity
- Clinical Trials
- Biosimilars
- Antibody Engineering
- Glycosylation
- Febrile Neutropenia
- Angiogenesis
- Antigen Presentation
- Activation
- Macrophage
- Apoptosis
- Chimeric Antigen Receptor
- Lymphoma
- Cetuximab
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Tumor Microenvironment6▲ 33×7 topics
- Cancer5▲ 8.7×14 topics
- Chemotherapy5▲ 15×9 topics
- Monoclonal Antibodies4▲ 112×3 topics
- Immune Checkpoint Blockade4▲ 80×1 topic
- PD-1 and PD-L14▲ 80×1 topic
- Inflammation3▲ 3.6×14 topics
- Immunotherapy3▲ 10×8 topics
- Cancer Immunotherapy3▲ 44×3 topics
- Cancer Therapy3▲ 12×6 topics
- Immunity3▲ 16×3 topics
- Biopharmaceuticals3▲ 117×3 topics
- Immunogenicity2▲ 136×2 topics
- Therapeutic Antibodies2▲ 80×2 topics
- Clinical Trials2▲ 7.5×7 topics
- Bioanalytical Methods2▲ 226×1 topic
- Biosimilars2▲ 226×1 topic
- Hematological Malignancies2▲ 133×2 topics
- Antibody Engineering2▲ 78×1 topic
- Fc Receptors2▲ 78×1 topic
- Glycosylation2▲ 40×2 topics
- Antimicrobial Agents2▲ 244×1 topic
- Febrile Neutropenia2▲ 244×1 topic
- Targeted Therapy2▲ 18×5 topics
- Angiogenesis2▲ 11×7 topics
- Metabolism2▲ 7.2×4 topics
- Antigen Presentation2▲ 37×2 topics
- Innate Immunity2▲ 11×2 topics
- Activation1▲ 50×1 topic
- Dendritic Cells1▲ 37×1 topic
- Macrophage1▲ 41×1 topic
- Tumor Antigen1▲ 54×1 topic
- Apoptosis1▲ 9.7×5 topics
- CAR T Cells1▲ 40×1 topic
- Chimeric Antigen Receptor1▲ 40×1 topic
- Leukemia1▲ 36×2 topics
- Lymphoma1▲ 19×2 topics
- Tumor Regression1▲ 27×2 topics
- Cetuximab1▲ 33×2 topics
- Molecular Subtypes1▲ 29×2 topics
Which research topics does Coherus BioSciences (United States) publish most on?
By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Biosimilars and Bioanalytical Methods, Monoclonal and Polyclonal Antibodies Research and Neutropenia and Cancer Infections.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 2 Biosimilars and Bioanalytical Methods Immunology 2 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 4 Neutropenia and Cancer Infections Oncology 2 works
- 5 Immunotherapy and Immune Responses Immunology 1 works
- 6 Immune cells in cancer Immunology 1 works
- 7 CAR-T cell therapy research Oncology 1 works
- 8 Colorectal Cancer Treatments and Studies Oncology 1 works
- 9 Cancer-related Molecular Pathways Oncology 1 works
- 10 Blood disorders and treatments Genetics 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Coherus BioSciences (United States)'s research output changed?
Output in 2022-2025 was 120% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Coherus BioSciences (United States) as a percentage of every work published that year, 0.00020% in 2024.
Fractional works of Coherus BioSciences (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Redwood City
- Heron Therapeutics (United States)
- Chan Zuckerberg Initiative (United States)
- Emergency University
- Guardant (United States)
- Box (United States)
- OncoMed (United States)
- Genomic Health (United States)
- Ubiquitous Energy (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Coherus BioSciences (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.